Skip to content

Batch information on every product pageTHC < 0.3%Shipped from France10% off when you sign up

CP-55,244

A tricyclic non-classical cannabinoid from Pfizer, a research tool of very high affinity at the CB1 receptor.

Level of detail

Harm-reduction warning

No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.

C₂₆H₄₂O₃

CAS 79732-51-7

Family
Synthetic CB receptor agonistResearch ligand or medicine
Molar mass
402.60 g/mol

Updated on

In plain terms

CP-55,244 is a laboratory cannabinoid, made rigid, used as a research tool at the CB1 receptor. In published assays it proves very potent. It is not meant to be consumed.

Receptors and activity

Target network

CB1AgonistEC50 = 0.5 nM · rat[35S]GTPγS binding, rat cerebellar membranes; Ki = 1.4 ± 0.3 nM cited by Lagu 1995
  • Activates

The lower the cited value, the closer the target sits to CP-55,244: one ring per factor of 100. A target with no measured value stays on the edge.

Where these targets live

Where each target has been found in humans, according to the cited studies. The map shows the target, not an effect of CP-55,244.

Brain, side view
Body, front view
Blood

CB1CB1 found in 7 regions of the body

  1. Basal gangliadenseMost dense in basal ganglia outflow nuclei1
  2. CerebellumdenseVery dense in the cerebellum1
  3. HippocampusdenseVery high concentrations in the hippocampus2
  4. AmygdaladenseHigh concentrations in the amygdala2
  5. CortexpresentPresent throughout the neocortex2
  6. Adipose tissuepresentExpressed in adipose tissue3
  7. GutpresentColonic epithelium, smooth muscle and plexus4

Cited values

  1. CB1AgonistEC50 = 0.5 nM · rat89 out of 100

    Griffin et al. 1998, J Pharmacol Exp Ther (new tab) · [35S]GTPγS binding, rat cerebellar membranes; Ki = 1.4 ± 0.3 nM cited by Lagu 1995

  2. CB2Agonistno measured value cited

    Assessed at rat, mouse and recombinant human receptors (Govaerts 2004); value not found in the abstract

Bar length follows the measured value (Ki, Kd, EC50 or IC50), on one scale shared by every entry, from 100 µM to 0.1 nM. A target with no cited value has no bar.

Pharmacology

CP-55,244 is a non-classical cannabinoid of the ACD-tricyclic type: its phenol with a 1,1-dimethylheptyl chain is carried by a decalin that fixes the position of the hydroxypropyl group of CP-55,940 (Melvin et al. 1995). In rat cerebellar membranes, it stimulates [35S]GTPγS binding with an EC50 of 0.47 nM, values that the authors place at the top end of the range observed (Griffin et al. 1998). In mice, (-)-CP-55,244 and (-)-CP-55,940, which lack the pyran ring, are 5 to 775 times more potent than Δ9-THC on several behavioural measures (Little et al. 1988), and (-)-CP-55,244 is about 1000 times more potent than Δ9-THC at enhancing [3H]flunitrazepam binding and in an analgesic activity measured in animals (Koe et al. 1985). Richardson et al. (1990) took it as the basis for affinity ligands of the cannabinoid receptor. No human data were found: the compound is a pharmacological tool.

History

Source
A wholly synthetic compound, with no natural occurrence, used as a pharmacological research tool at the cannabinoid receptor (see Griffin et al. 1998; Govaerts et al. 2004). No report of circulation outside the laboratory was found in the sources consulted.

Origin

Laboratory synthesis

No biological pathway: CP-55,244 is entirely synthetic and belongs to the class of the non-classical cannabinoids, without the pyran ring of THC.

Classification

Family, origin and source verification

Family

Synthetic CB receptor agonist › Research ligand or medicine

Class

non-classical

Verification

Classification, sources and binding values checked on 20 October 2026; text read against its sources and Wikipedia.

Wikipedia (English)

CP 55,244 (new tab)

Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.

References

Identifiers

Names

IUPAC name
(2R,4R,4aR,6S,8aS)-6-(hydroxymethyl)-4-[2-hydroxy-4-(2-methyloctan-2-yl)phenyl]-1,2,3,4,4a,5,6,7,8,8a-decahydronaphthalen-2-ol
Other names
CP 55,244 · CP-55244 · CP55244

Identifiers

Formula
C₂₆H₄₂O₃
CAS
79732-51-7
PubChem CID
9844074(new tab)
InChIKey
ZAELPWSCABXXAB-NWXGMGMZSA-N
SMILES
CCCCCCC(C)(C)C1=CC(=C(C=C1)[C@@H]2C[C@@H](C[C@H]3[C@H]2C[C@H](CC3)CO)O)O

Machine-readable entry (JSON)

LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.